Your SlideShare is downloading. ×
Anaesthetic Management of Diabetes Mellitus in Pediatrics
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Anaesthetic Management of Diabetes Mellitus in Pediatrics

2,138
views

Published on

Published in: Health & Medicine

0 Comments
6 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
2,138
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
6
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • Replace table
  • Transcript

    • 1. Anesthetic Management Of Pediatric Diabetes mellitus
      Prof. Dr. AzzaEzzat
      Professor of Anesthesiology
      Cairo University
    • 2. Dealing with diabetic child is a challenge , not only to the anesthiologist but also to endocrinologist .
      Why?
      It is difficult to control their meals
      It is also difficult to put them on diet regimens
      Limited management options
      Frequent injection (fear of repeated insulin injection )
    • 3. Our aim
      Is to do safe perioperative management
      Providing balanced glycemic control
      Avoiding hypoglycemia with its serious brain insult in this age group.
      Also preventing excessive hyperglycemia with it’s dangerous sequel.
    • 4. Pancreas
      • The pancreas is a dual function gland
      • 5. Endocrine function:
      • 6. a cells secrete glucagon blood glucose
      • 7. b cells secrete insulin blood glucose
      • 8. g cells secrete somatostatinregulate & stop a & b
      • 9. Pp cells secrete pancreatic polypeptides
    • Pancreas
      • Exocrine function:
      • 10. Digestive enzymes
      • 11. Pancreatic juice
      both are secreted into the
      small intestine directly
    • 12. Regulation of insulin secretion
      Insulin is secreted into the portal venous system in the basal state at rate of approximately 1 u/h .
      Food intake results in a prompt five to ten fold increase in the rate of insulin secretion
      Insulin is not secreted when the blood glucose level <50 mg /dl
      Max. stimulation of insulin release when blood glucose level >300 mg/dl
    • 13. Regulation of insulin secretion
      Stimulation
      Hyperglycemia
      Beta adrenergic agonists
      Acetyl choline
      Glucagon
      Inhibition
      Hypoglycemia
      Beta adrenergic antagonists
      Alpha-adrenergic agonists
      Somatostatin
      Diazoxide
      Thiazide diuretics
      Volatile anesthetics
      Insulin
    • 14. Role of insulin
      It facilitates transport of glucose across cell membranes and enhances phosphorylation of glucose within cells
      It promotes the use of CHO for energy conservation while depressing the use of fat and amino acids
      • Increases glucose and K entry into the cells
      Excess glucose is stored in :
      -The liver as glycogen
      -Adipose tissue as fat
      -Skeletal muscle as protein and glycogen
    • 15.
    • 16. Sequels of insulin deficiency
      So insulin stimulates ANABOLISM and prevents CATABOLISM
    • 21. Diabetes Mellitus
      Prevalence: 0.7/1000 this is according to 2007 records at the Cairo university pediatric hospital
      Follow-up: 6000 children
      • Risk factors include:
      • 22. environmental e.g. viral infection
      • 23. genetic predisposition
    • Diabetes Mellitus
      Decreased or diminished effectiveness of insulin
      Characterized by impairment of carbohydrate metabolism
      Resulting in hyperglycemia and glycosuria
      Plasma  140 mg / dl
      Blood > 126 mg / dl
      FBS
      Plasma contains 12% more sugar
    • 24. Classification of diabetes
    • 25. Pathophysiology
      Insulin deficiency causes physiologic and metabolic changes in the body
      Glucose from dietary sources cannot be utilized by the cells
      Renal tubules have difficulty reabsorbing the glucose
    • 26. Pathophysiology
      • If the blood glucose level exceeds the renal threshold for glucose osmotic diuresis ensues.
      • 27. Renal threshold: when serum glucose levels approach 200mg/dl the renal tubules have difficulty re-absorbing the glucose
      • 28. Hyperglycemia impairs leukocyte function.
    • Clinical Manifestations
      Elevated blood glucose leads to osmotic diuresis. (polyuria and thirst)
      Protein and fat breakdown lead to weight loss.
      Accumulation of ketones causes a drop in pH. (metabolic acidosis) and spilling of ketones in the urine
    • 29. Presenting Symptoms
      • Hyperglycemia / glucose in blood stream
      • 30. Glucosuria / sugar in urine
      • 31. Polyuria / increased urine output
      • 32. Electrolyte imbalance from dehydration
      • 33. Polydipsia / attempt to relieve dehydration
      • 34. Polyphagia / attempt to compensate for lost calories
    • Diagnostic Tests
      Blood glucose levels greater than 200 mg/dl
      Urine sample reveals glucosuria and possible ketonuria
      Glucose tolerance test would reveal low insulin levels in the face of elevated glucose levels
    • 35. Goals of Management
      Short term goals:
      Prevent the development of ketosis.
      Prevent electrolyte abnormalities and volume depletion secondary to osmotic diuresis.
      Prevent impairment of leukocyte function
      Prevent impairment of wound healing
      Long term goal: prevention of microcirculatory and neuropathic changes
    • 36. Blood Glucose Levels
      Target levels
      Toddler and preschool: 100 to 180 mg/dl
      School-age: 90 to 180 mg/dl
      Adolescents (13 to 19 years): 90 to 130 mg/dl
    • 37. Common types of DM in pediatrics
      Type 1 DM which is caused by pancreatic β cell destruction usually immune mediated. It results in absolute insulin deficiency. Incidence (11.7- 17.8/ 100000).
      Type 2 DM results from a combination from insulin resistance and relative deficiency of insulin.*
      *Diabetes Care 2004
    • 38. Management Options for DM in Pediatrics
      • Insulin regimens
      Insulin regimens incorporate a combination of intermediate and long acting insulin with short or rapid insulin (2-3 injections/day)
      Insulin Pump (SC)
      Continuous administration of rapid
      acting insulin at a basal rate
      and supplemented with additional
      doses before meal or snacks.
    • 39.
    • 40. An easy to handle insulin pump
    • 41. Insulin Preparations classified according to pharmacodynamic profiles
    • 42. Short Acting Insulin
      • Short acting (Soluble, Regular) insulin is used as an essential component of most daily replacement regimens.
      - In combination with intermediate acting insulin - As premeal bolus injections 20-30 minutes before meals.
      - It is the only insulin suitable for IV therapy.
    • 43. Rationale for insulin Glargine
      Insulin glargine was designed to provide a constant basal insulin concentration to control basal metabolism with one injection daily
      Insulin Glargine is indicated for the treatment of adult and pediatric patients (over the age of 6 years) with type I diabetes.
    • 44.
    • 45. Summary of types of insulin
      Rapid acting = ultra short (neonates & infants) with meal (lactation)
      Short acting = regular insulin (all ages)
      Intermediate at basal rate (children & infants)
      Long acting (pre puberty i.e. 10 years)
      Galargine (not less than 6 years if used pre puberty)
    • 46. Oral Antihyperglycemics
      Metformine is the only drug approved in pediatric population.
      Action:
      - It decreases hepatic glucose production.
      - It increases insulin sensitivity in peripheral tissues.
    • 47. Metabolic Response for Surgery and Anesthesia
      • Suppression of insulin secretion.
      • 48. Increased production of counter regulatory hormones ( Cortisol, Catecholamines, GH, Glucagon)
      • 49. NPO (starvation) has catabolic effect leading to lipolysis and glycogenolysis.
      • 50. Transient phase of insulin resistance after surgery. *
      *Angelini G, 2001
    • 51. Adverse Consequences of Hyperglycemia
      Immediate
      DKA (Dehydration – Metabolic acidosis)
      Remote
      - Delayed wound healing
      - Increased incidence of infection
      (↓ neutrophils activity)
    • 52. Preoperative Assessment
      Blood Glucose
      Metabolic Control
      Electrolyte balance
      Glycosylated Hb
      ↓ 5 years 7% to 9%
      5-13 years 6% to 8.5%
      ↑ 13 years 6% to 8%
    • 53. On the day of surgery Short procedure
      Withhold morning dose
      Glucose-free solution
      When postoperative oral intake is established 40 – 60 % of usual daily dose is administered
    • 54. On the day of surgeryLong ProcedureIf Blood Glucose 100 – 200 mg/dl
      Hold rapid or short acting insulin.
      Administration 50% the intermediate or long acting insulin.
      Omit breakfast
      Patient scheduled first case (Avoid starvation).
      Rhodes et al 2005
    • 55. Insulin Infusion
      - Add soluble insulin 50 units to 50 ml NS 0.9%.
      - Start infusion at:
      0.025 ml/kg/h if blood glucose is < 6-7 mmol/l
      0.05 ml/kg/h if blood glucose is 8-12 mmol/l
      0.075 ml/kg/h if blood glucose is 5-10 mmol/l
      0.1 U/kg/h if blood glucose is > 15 mmol/l
      - Aim to maintain BG between 5-10 mmol/l .
      - BG must be measured at least hourly when the patient is on IV inf.
      - Do not stop the insulin infusion if BG < 5-6 mmol/l (90 mg/dl) as this will cause rebound hyperglycemia. Reduce the rate of infusion.
      - The insulin infusion may be stopped temporarily if BG < 4mmol/l (55 mg/dl) but only for 10-15 min.
      Bett et al 2009
    • 56. On the day of surgeryLong ProcedureIf Blood Glucose > 250 mg/dl
      On the morning of surgery:
      No rapid or short-acting insulin is given unless blood glucose is > 250 mg/dl
      >250 mg/dl  give a dose of rapid-acting insulin using “correction factor”
      Correction factor: The decrease in blood glucose level expected after administering 1 unit of rapid acting insulin
    • 57. How to calculate corrective dose?
      Using the rule of 1500 for regular insulin
      Example:
      The total daily dose of a child is 30 U
      So the correction factor = 1500/30 = 50
      i.e. each unit of insulin will decrease his blood glucose level by 50 mg/dl
      If this child’s blood glucose level = 300 mg/dl and his target glucose level = 150 mg/dl
       his corrective dose = 300 – 150/50 = 3 U
      OR
      0.1 u/kg SC of rapid acting insulin
    • 58. Anesthetic management
      • Scheduling the diabetic child as the first case to shorten the fasting hours (NPO like non diabetic)
      • 59. Use of premedication
      • 60. No premedication: to monitor signs and symptoms of hypoglycemia
      • 61. Premedication: Anxiety may increase blood glucose level
      The Aim is to keep blood glucose 100 – 200 mg/dl
      Keep Them Sweet
    • 62. Metformin withhold 24 hrs preoperative
      Sulfonylurea withhold on morning of surgery
      Preoperative for child on Oral Hypoglycemics
    • 63. Intraoperative
      Keep blood glucose 100-200 mg/dl.
      Potassuim: assessment of level of electrolyte especially in lengthy procedures.
      Fluid maintenance 1500 ml/m2/day.
      Iv insulin
      <12 years: 1 u/5g glucose
      >12 years: 1 u/3g glucose
    • 64. Postoperative Management
      • Once the child resumes oral intake restart his insulin or oral hypoglycemic regimen.
      • 65. Insulin dosing for previously non diabetic children
      • 66. 0.6 – 0.8 U/kg/day (prepuberty)
      • 67. 1 – 1.5 U/kg/day (Adolscence)
    • Hypoglycemia
      Blood glucose level
      < 60 mg / dl ( children )
      < 40 mg / dl (neonates )
      Diabetic patients can not combat hypoglycemia by secreting glucagon and adrenaline
    • 68. Hypoglycemia
      • Treatment
      • 69. Glucose infusion:
      • 70. In neonates:
      • 71. Administer 2 mL/kg of D10%W followed by a continuous infusion of 6-8 mg/kg/min to maintain blood glucose level 70-120 mg/dl
      • 72. In children:
      • 73. 0.5-1 g/kg, which is equal to 2-4 ml/Kg of D25% or 5-10 ml/Kg of D10% or 10-20 ml/Kg of D5%
      • 74. If hypoglycemia persists, you may increase glucose infusion to 8-15 mg/kg/min.
    • Diabetic Ketoacidosis
      • Definition : Diabetic ketoacidosis (DKA) is a complex metabolic state of hyperglycemia, ketosis, and acidosis
      • 75. Causes :
      • 76. Infection is the most frequent cause of diabetic ketoacidosis, particularly in patients with known diabetes
      • 77. Missed insulin doses
      • 78. Pathophysiology :
      Hyperglycemia Osmotic diuresis loss of free water and electrolytes Hypovolemia tissue hypoperfusion and lactic acidosis
      The ketoacids (acetoacetate, beta-hydroxybutyrate, acetone) are products of proteolysis and lipolysisKETOACIDOSIS
      Potassium is the most important electrolyte in patients with severe diabetic ketoacidosis ( Hyperkalemia or Hypokalemia)
    • 79. Management
      • The goal of the first hour of treatment
      • 80. volume resuscitation
      • 81. confirmation of diabetic ketoacidosis by laboratory studies
      • 82. Management of urgent airway, breathing, and circulation
      • 83. Fluid therapy :
      • 84. Isotonic sodium chloride solution bolus, 20 mL/kg intravenously over an hour or less then gradual replacement over the succeeding hours
      • 85. Add 5% dextrose to intravenous fluids, if the child remains in ketoacidosis and serum glucose level approaches 250-300 mg/dL
      • 86. The goals of the second and succeeding hours :
      slow correction of hyperglycemia (with glucose level falling at a rate <100 mg/dL/h), metabolic acidosis, and ketosis, in addition to continued volume replenishment
      • Insulin :
      • 87. Do not give insulin until severe hypokalemia is corrected
      • 88. Then give 0.1 U/kg regular insulin intravenous bolus; follow with insulin 0.1 U/kg/h intravenously by constant infusion
      • Do not discontinue the insulin drip, as the child remains in ketoacidosis for some time and insulin is critical in eliminating ketoacidosis
      • 89. Initiate insulin therapy after beginning fluid replacement and serum potassium correction
      • 90. Potassium :
      • 91. Once the child has been resuscitated, potassium should be commenced immediately with rehydration fluid unless anuria is suspected
      • 92. Potassium is mainly an intracellular ion, and there is always massive depletion of total body potassium although initial plasma levels may be low, normal or even high
      • 93. Levels in the blood will fall once insulin is commenced
      • 94. If serum potassium level is greater than 5.5 mmol per litre, do not add additional potassium to intravenous fluids
      • 95. The final goal is to obtain a serum glucose concentration within the reference range (serum glucose level, 100-150 mg/dL), to obtain neutral blood pH (pH =7.4; serum bicarbonate = 15-18 mEq/dL), and to eliminate serum ketones.
      • 96. Identification and treatment of the precipitant event, antibiotic for infection
      • 97. Hourly monitoring of serum markers of diabetic ketoacidosis
    • Remember
      • Assess for other associated endocrine or congenital disease.
      • 98. Fasting diabetic child should be scheduled first case.
      • 99. Elective cases should be euglycemic.
      • 100. Avoid drugs that increase blood glucose e.g. ketamine and pancronium.
      • 101. Target blood glucose level is 100-200 mg/dl.
    • Remember
      • Insulin should be infused through a separate line.
      • 102. The decrease in blood glucose level should be at a rate not more than 50-100 mg/dl/hr.
      • 103. Glucose 25% is not used in pediatrics (vascular injury).
      • 104. Assess blood glucose level every 1-1.5 hr.
      • 105. 0.1 g/kg dextrose will raise blood glucose level by about 30 mg/dl.
    • Remember
      Adequate planes of anesthesia and analgesia is necessary to avoid hyperglycemia secondary to stress response or lack of analgesia.
    • 106. Thank You
    • 107. Pancreas
      • b cells of Islets of Langerhans secret 50 units of insulin /day
      • 108. Insulin
      • 109. Secretion determined by blood glucose level
      • 110. Anabolic hormone
      • 111. Increases glucose and K entry into the cells
      • 112. Increased synthesis of Glycogen, Protein and fatty acid synthesis
    • Effects of insulin on liver
      Anabolic
      • Promotes glycogenesis
      • 113. Increases synthesis of
      triglyceride
      cholesterol
      VLDL proteins
      • Increases protein
      synthesis
      • Promotes glycolysis
      Anticatabolic
      • Inhibits glycogenolysis
      • 114. Inhibits ketogenesis
      • 115. Inhibits gluconeogenesis
    • Effects of insulin on muscle
      • Promotes protein synthesis
      Increases amino acid transport
      Stimulates ribosomal protein synthesis
      • Promotes glycogen synthesis
      Increases glucose transport
      Enhances activity of glycogen synthetase
      Inhibits activity of glycogen phosphorylase
    • 116. Effects of insulin on fat
      • Promotes triglycerides storage
      • 117. Fatty acids absorption into fat cells
      • 118. Increase glucose transport into fat cells
      • 119. Inhibits intra-cellular lipolysis
    • A young boy with an insulin pump device